Date published: 2026-5-8

1-800-457-3801

SCBT Portrait Logo
Seach Input

Nanos2 Inhibitors

Nanos2 inhibitors represent a specialized class of chemical compounds that interact with and inhibit the function of the Nanos2 protein, a critical regulator within the germline and somatic cells. Nanos2 is part of the Nanos family of RNA-binding proteins, which play an essential role in post-transcriptional regulation by binding to specific mRNA targets and controlling their stability and translation. The inhibition of Nanos2 disrupts its role in mRNA silencing, thereby affecting the precise balance of gene expression necessary for the proper maintenance of cellular functions, particularly in the context of cellular differentiation, stem cell maintenance, and development. The design and synthesis of Nanos2 inhibitors often focus on identifying molecules that can effectively bind to the RNA-binding domain of Nanos2 or disrupt its interaction with other co-factors, thereby blocking its regulatory function. These inhibitors are generally identified through high-throughput screening methods or rational drug design, where the structural understanding of Nanos2 is leveraged to create compounds with high specificity and potency. Research into Nanos2 inhibitors has led to the development of a variety of molecules with distinct chemical structures, including small molecules, peptides, and even nucleic acid-based inhibitors such as antisense oligonucleotides. Each of these classes of inhibitors targets different aspects of Nanos2 function, from direct binding to the RNA recognition motif to interference with protein-protein interactions essential for its activity. The study of these inhibitors has also provided significant insights into the broader role of Nanos2 in cellular processes like germline development, the regulation of pluripotency in stem cells, and the fine-tuning of the cell cycle. Additionally, the structural diversity of these inhibitors highlights the complexity of targeting RNA-binding proteins, which often lack well-defined binding pockets typical of enzymes or receptors, thus requiring innovative approaches in inhibitor design. Overall, Nanos2 inhibitors serve as valuable tools for dissecting the molecular mechanisms of RNA regulation and provide a platform for further exploration of post-transcriptional gene control mechanisms within various biological systems.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Spliceostatin A

391611-36-2sc-507481
1 mg
$1800.00
(0)

Spliceostatin A targets the spliceosome, potentially affecting RNA splicing processes involved in NANOS2 regulation.

Pladienolide B

445493-23-2sc-391691
sc-391691B
sc-391691A
sc-391691C
sc-391691D
sc-391691E
0.5 mg
10 mg
20 mg
50 mg
100 mg
5 mg
$299.00
$5699.00
$11099.00
$25500.00
$66300.00
$2875.00
63
(2)

Pladienolide B inhibits spliceosome function, which could impact the processing of RNAs regulated by NANOS2.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Actinomycin D binds to DNA and inhibits transcription, potentially affecting NANOS2 expression or its target genes.

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$90.00
$204.00
13
(1)

Triptolide is a diterpene triepoxide that inhibits RNA Polymerase II, potentially impacting NANOS2 expression.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$131.00
$515.00
2
(1)

RG108, a DNA methyltransferase inhibitor, can alter gene expression patterns, potentially affecting NANOS2.

Leptomycin B

87081-35-4sc-358688
sc-358688A
sc-358688B
50 µg
500 µg
2.5 mg
$107.00
$416.00
$1248.00
35
(2)

Leptomycin B, an inhibitor of nuclear export, could impact the localization and function of NANOS2.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$231.00
$863.00
1
(0)

JQ1, a BET bromodomain inhibitor, might influence gene expression relevant to NANOS2's function.

Puromycin dihydrochloride

58-58-2sc-108071
sc-108071B
sc-108071C
sc-108071A
25 mg
250 mg
1 g
50 mg
$42.00
$214.00
$832.00
$66.00
394
(16)

Puromycin inhibits protein synthesis, potentially affecting proteins regulated by or interacting with NANOS2.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Cycloheximide inhibits eukaryotic protein synthesis, which might indirectly affect NANOS2 function.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin, an mTOR inhibitor, can affect cell growth and proliferation, potentially influencing NANOS2-related pathways.